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a b s t r a c t 
The relationships between clinical phenotype, β-amyloid (A β) deposition and neurodegeneration in 
Alzheimer’s disease (AD) are incompletely understood yet have important ramiﬁcations for future ther- 
apy. The goal of this study was to utilize multimodality positron emission tomography (PET) data from a 
clinically heterogeneous population of patients with probable AD in order to: (1) identify spatial patterns of 
A β deposition measured by ( 11 C)-labeled Pittsburgh Compound B (PiB-PET) and glucose metabolism mea- 
sured by FDG-PET that correlate with speciﬁc clinical presentation and (2) explore associations between 
spatial patterns of A β deposition and glucose metabolism across the AD population. We included all patients 
meeting the criteria for probable AD (NIA–AA) who had undergone MRI, PiB and FDG-PET at our center 
( N = 46, mean age 63.0 ± 7.7, Mini-Mental State Examination 22.0 ± 4.8). Patients were subclassiﬁed 
based on their cognitive proﬁles into an amnestic / dysexecutive group (AD-memory; n = 27), a language- 
predominant group (AD-language; n = 10) and a visuospatial-predominant group (AD-visuospatial; n = 9). 
All patients were required to have evidence of amyloid deposition on PiB-PET. To capture the spatial distri- 
bution of A β deposition and glucose metabolism, we employed parallel independent component analysis 
(pICA), a method that enables joint analyses of multimodal imaging data. The relationships between PET 
components and clinical group were examined using a Receiver Operator Characteristic approach, including 
age, gender, education and apolipoprotein E 4 allele carrier status as covariates. Results of the ﬁrst set of
analyses independently examining the relationship between components from each modality and clinical 
group showed three signiﬁcant components for FDG: a left inferior frontal and temporoparietal component 
associated with AD-language (area under the curve [AUC] 0.82, p = 0.011), and two components associated 
with AD-visuospatial (bilateral occipito-parieto-temporal [AUC 0.85, p = 0.009] and right posterior cingulate 
cortex [PCC] / precuneus and right lateral parietal [AUC 0.69, p = 0.045]). The AD-memory associated com- 
ponent included predominantly bilateral inferior frontal, cuneus and inferior temporal, and right inferior 
parietal hypometabolism but did not reach signiﬁcance (AUC 0.65, p = 0.062). None of the PiB components 
correlated with clinical group. Joint analysis of PiB and FDG with pICA revealed a correlated component pair, 
in which increased frontal and decreased PCC / precuneus PiB correlated with decreased FDG in the frontal, 
occipital and temporal regions (partial r = 0.75, p < 0.0001). Using multivariate data analysis, this study 
reinforced the notion that clinical phenotype in AD is tightly linked to patterns of glucose hypometabolism 
but not amyloid deposition. These ﬁndings are strikingly similar to those of univariate paradigms and provide 
additional support in favor of speciﬁc involvement of the language network, higher-order visual network, 
and default mode network in clinical variants of AD. The inverse relationship between A β deposition and Abbreviations: AD or AD-memory, Alzheimer’s disease; AUC, area under the curve; 
D-language or LPA, logopenic variant primary progressive aphasia; PCA or AD- 
isuospatial, posterior cortical atrophy; PCC, posterior cingulate cortex; PPC, posterior 
arietal cortex. 
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glucose metabolism in partially overlapping brain regions suggests that A β may exert both local and re- 
 
 
 
 
 mote effects on brain metabolism. Applying multivariate approaches such as pICA to multimodal imaging
data is a promising approach for unraveling the complex relationships between different elements of AD
pathophysiology. 
c © 2014 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND license
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 Introduction 
The relationships between amyloid, metabolism and clinical phe-
notype in Alzheimer’s disease (AD) are incompletely understood. Pre-
vious studies have yielded mixed results within typical amnestic AD
and across different AD phenotypes. For example, in three clinical
variants of AD (AD-memory, AD-language, AD-visuospatial), clinical
syndromes were strongly linked to patterns of glucose metabolism,
whereas ( 11 C)-labeled Pittsburgh Compound B (PiB-PET) binding was
similar across clinical phenotypes ( Cohen et al., 2009 ; de Souza et al.,
2011 ; Lehmann et al., 2013a ; Leyton et al., 2011 ; Rabinovici et al.,
2008 ; Rosenbloom et al., 2011 ). Correlations between increased β-
amyloid and decreased metabolism have been found in some studies
( Cohen et al., 2009 ; Edison et al., 2007 ; Engler et al., 2006 ) but not in
others ( Furst et al., 2012 ; Li et al., 2008 ). Some studies have suggested
that the relationships between amyloid and glucose metabolism vary
by brain region and disease state ( Cohen et al., 2009 ; La Joie et al.,
2012 ). 
To date, most studies have investigated these relationships us-
ing univariate analyses, but this approach may fail to capture dis-
tributed variations across brain networks. A number of recent stud-
ies have demonstrated that multivariate statistical paradigms (e.g.,
principal component analysis or independent component analysis
[ICA]), where distributed variations in multiple neuroimaging data
and their inter-relationships are assessed together, provide a better
framework for integrative analysis of imaging data. Multivariate tech-
niques have been shown to be more sensitive for early diagnosis of AD
and capture patterns of normal age-associated atrophy ( Brickman et
al., 2007 ). Parallel independent component analysis (pICA; Calhoun et
al., 2006 ), a variation of ICA which allows estimation of independent
components as well as multimodal patterns or mixed coefﬁcients,
has recently been used to study the mechanisms by which amyloid- β
deposition leads to neurodegeneration and cognitive decline ( Tosun
et al., 2011 ). This is particularly relevant in light of possible distant
( Bourgeat et al., 2010 ) rather than local ( Cohen et al., 2009 ) effects of
β-amyloid on glucose metabolism. 
In this study we applied a multivariate approach to explore the
relationships between metabolism and amyloid accumulation across
AD phenotypes. To this end, we recruited patients with three pheno-
types of AD cited in the new clinical diagnostic guidelines ( McKhann
et al., 2011 ): 1) a group of prototypical AD, or AD-memory, charac-
terized by predominant episodic memory impairment and executive
dysfunction ( Dubois et al., 2007 ), 2) a group with language variant
AD (AD-language, also called logopenic variant primary progressive
aphasia ) characterized by progressive word-ﬁnding difﬁculties and
deﬁcits in sentence repetition ( Gorno-Tempini et al. , 2004 , 2011 ),
and 3) a group with the visuospatial variant of AD (AD-visuospatial,
also referred to as posterior cortical atrophy ) marked by predominant
visuospatial and visuoperceptual dysfunctions. We then applied pICA
to 1) identify speciﬁc components from each modality that correlated
with clinical presentation and 2) identify relationships between spa-
tial patterns of PiB and FDG across AD patients. Based on previous
results applying univariate statistics from our group and others, wehypothesized that FDG but not PiB would generate individual com-
ponents that correlated with diagnosis. We further aimed to capture
relationships between spatial patterns of glucose metabolism and
amyloid deposition in this clinically and anatomically diverse cohort
which may not be apparent using traditional univariate methods. 
2. Subjects and methods 
2.1. Subject selection and characteristics 
We identiﬁed all patients seen at the University of California San
Francisco (UCSF) Memory & Aging Center who met the criteria for
probable AD according to the National Institute on Aging–Alzheimer’s
Association (NIA–AA) guidelines ( McKhann et al., 2011 ), were PiB-
positive and had available FDG and MRI scans. Patients were excluded
if they had clinical or imaging evidence of previous stroke, or had a
high burden of white matter hyperintensities (deﬁned as Scheltens
grade ≥ 4) ( Scheltens et al., 1998 ). All patients were recruited be-
tween April 2005 and July 2011. Patients underwent a history and
physical examination by a behavioral neurologist, a structured care-
giver interview by a nurse, and a battery of neuropsychological tests
( Kramer et al., 2003 ). All patients had mild-to-moderate dementia
based on the Mini-Mental State Examination (MMSE; Folstein et al.,
1975 ) and the Clinical Dementia Rating (CDR; Morris, 1993 ) scale.
Diagnosis was made in a consensus clinical conference incorporat-
ing clinical and neuropsychological proﬁles but blinded to imaging
data. Patients were subclassiﬁed as AD-memory, AD-language, and
AD-visuospatial using published criteria ( Gorno-Tempini et al., 2011 ;
McKhann et al., 2011 ; Tang-Wai et al., 2004 ). The AD-memory group
was composed of patients meeting the NIA–AA criteria for probable
AD but not AD-language or AD-visuospatial criteria. The ﬁnal cohort
consisted of 27 patients with probable AD-memory, ten with AD-
language and nine with AD-visuospatial (see Table 1 ). 
2.2. Imaging 
Acquisition parameters for all scanners have been described in
previous publications ( Mormino et al., 2012 ; Mueller et al., 2009 ;
Rabinovici et al., 2007 ; Rosen et al., 2002 ; Zhou et al., 2012 ). 
2.3. Structural imaging 
T 1 -weighted scans were collected at UCSF or Lawrence Berkeley
National Laboratory (LBNL) on different MRI units, including two 1.5 T
units (Magnetom Avanto System, Siemens Medical Systems, Erlangen,
Germany; Magnetom VISION system, Siemens Inc., Iselin, NJ), a 3 T
unit (Siemens Tim Trio scanner), and a 4 T unit (BrukerMedSpec). The
proportions of subjects studied on each scanner were balanced across
the three AD groups. In patients with multiple MRIs, the MRI closest
to the date of the PET scan was used for data preprocessing. 
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Table 1 
Patient characteristics. 
Groups AD-memory ( n = 27) AD-language ( n = 10) AD-visuospatial ( n = 9) p values 
Age (mean, SD) 68.0 (10.7) 60.1 (5.7) 61.0 (6.7) 0.03 * 
M / F 16 / 11 5 / 5 6 / 3 0.84, ns 
Education (mean, SD) 16.8 (2.5) 16.6 (3.4) 15.8 (3.5) 0.68, ns 
ApoE 4 status 0.07, ns 
- Absent 4 8 7 5 
- 1 4 14 3 2 
- 2 4 5 0 2 
MMSE / 30 22.2 (5.0) 23.1 (3.7) 21.2 (5.8) 0.71, ns 
CDR 0.96 (0.36) 0.55 (0.16) 0.67 (0.35) 0.002 * 
CDR-SB 6.2 (3.4) 3.0 (1.8) 4.6 (2.7) 0.02 * 
Abbreviations: Alzheimer’s disease (AD); standard deviation (SD); apolipoprotein E 4 allele (ApoE 4); Mini-Mental State Examination (MMSE); Clinical Dementia Rating (CDR); 
Clinical Dementia Rating Sum of Boxes (CDR-SB). 
∗p < 0.05. 
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a.4. Positron emission tomography radiochemistry and acquisition 
[ 11 C]PiB was synthesized at the LBNL Biomedical Isotope Facility 
sing a previously published protocol. [ 18 F]FDG was purchased from 
 commercial vendor (IBA Molecular). PET scans were performed at 
BNL using a Siemens ECAT EXACT HR PET scanner in 3-dimensional 
cquisition mode. 90 min of dynamic PiB data and 30 min of FDG data 
 t = 30–60 min post-injection, minimum of 2 h after PiB injection) 
ere obtained. Ten-minute transmission scans for attenuation correc- 
ion were obtained either immediately before or after each [ 11 C]PiB 
nd [ 18 F]FDG scan. PET data were reconstructed using an ordered sub- 
et expectation–maximization algorithm with weighted attenuation. 
mages were smoothed with a 4 mm Gaussian kernel with scatter cor- 
ection. All images were evaluated before analysis for patient motion 
nd adequacy of statistical counts. 
.5. Image processing 
All image pre-processing was performed in Statistical Paramet- 
ic Mapping version 8 (SPM8; http: // www.ﬁl.ion.ucl.ac.uk / spm ). 
eference regions were deﬁned in native MRI space for 
ach subject using subcortical parcellations from FreeSurfer 
.5 ( http: // surfer.nmr.mgh.harvard.edu ). FDG-PET frames were 
ummed and standardized uptake value ratios (SUVR) were calcu- 
ated by normalizing the summed FDG image to mean activity in the 
ons for each subject. For PiB, voxel-wise distribution volume ratios 
DVRs) were calculated using Logan graphical analysis ( Logan et al., 
996 ) with the gray matter cerebellum time–activity curve used as a 
eference tissue input function ( t = 35–90 min) ( Price et al., 2005 ). 
.6. Spatial normalization 
PiB and FDG data were co-registered to the subject’s skull 
tripped T 1 -weighted MRI. To allow across-subject comparisons, each 
ubject’s T 1 -weighted MRI was normalized to MNI (Montreal Neuro- 
ogical Institute) space using the skull stripped ch2 template, and 
he derived normalization parameters were applied to the subject’s 
o-registered PiB and FDG volumes. All normalized images were 
moothed with a 12-mm Gaussian kernel. 
.7. Visual inspection 
Voxel-wise PiB DVR images from all subjects were qualitatively 
ssessed by an experienced PET researcher (W.J.J.) blinded to clinical 
iagnosis. Scans were read visually as positive or negative for cortical 
iB. A positive scan was deﬁned as a DVR image in which uptake was 
ubstantially greater in the cortex than in the white matter. Visual 
nspection based on these criteria has been validated previously as 
 reproducible and reliable estimate of increased PiB uptake when compared with quantitative analysis ( Mormino et al., 2012 ; Ng et al., 
2007 ; Rabinovici et al., 2011 ). 
2.8. Parallel ICA 
We analyzed PiB and FDG data jointly and took all image voxels 
into account simultaneously using pICA (Fusion ICA Toolbox: Calhoun 
et al., 2006 ; Rachakonda et al., 2008 ). The mathematical foundations 
of pICA are described in detail in Liu et al. (2009) . In this frame- 
work, pICA applied to multimodality imaging data aims to identify 
independent components in each image modality as well as the rela- 
tionships of these independent components across image modalities. 
Brieﬂy, ICA is run on each modality and a correlation measure is 
enforced between the mixing coefﬁcients of modalities during the 
analysis. In the context of this study, pICA identiﬁed spatially inde- 
pendent components of PiB and FDG while simultaneously revealing 
the largest variations across patients that PiB and FDG had in common. 
The number of signiﬁcant independent components in each modality 
was estimated using both the Akaike information criterion (AIC) and 
the minimum description length criterion. As a well-accepted order 
selection criterion, AIC maximizes the log-likelihood of the observed 
data based on the independent component set, with a penalty term 
that is directly proportional to the total number of independent com- 
ponents. The independent component set with the lowest AIC value 
is selected for a balance between the accuracy of ﬁtting and the com- 
plexity of the independent component model. For each modality, the 
loading parameters expressing the contribution of each independent 
component to the variance across subjects were estimated. Each in- 
dependent component for each modality was scaled to unit standard 
deviation, yielding z -score maps in the MNI template space. Because 
FDG-PET data is interpreted in terms of hypometabolism and PiB-PET 
data in terms of increased tracer retention, all FDG data were inverted 
(sign reversed). All component maps were thresholded at a z -score 
level of | z | ≥ 2.5 (99.4% cumulative probability) for visualization pur- 
poses. 
Based on these loading parameters, we computed Pearson’s cor- 
relation coefﬁcients for all pairs of PiB and FDG independent com- 
ponents while further accounting for variations in age, gender, ed- 
ucation and apolipoprotein E 4 allele (ApoE 4) carrier status. The 
Pearson’s correlation coefﬁcients were then used to identify signif- 
icant relationships between brain amyloid- β accumulation and hy- 
pometabolism after correction for multiple comparisons using a false 
discovery rate (FDR) at a signiﬁcance level of p < 0.05. Relationship to 
clinical group was examined using a Receiver Operator Characteristic 
approach, including age, gender, education, and ApoE 4 (present / 
absent) as covariates. The ROC analyses assessed the contribution of 
each component separately to the classiﬁcation of one clinical group 
from the other two (e.g., AD-memory versus AD-language and AD- 
visuospatial) within the general linear model framework, using the 
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 logit function as link between the linear predictor variable (i.e., load-
ing parameters of a component) and group as binomial outcome vari-
able (clinical group of interest = 1 versus rest = 0). 
2.9. Statistical analysis 
Group differences in demographic variables were examined us-
ing one-way analysis of variance or the Mann–Whitney U test. As
appropriate statistical analyses were implemented in R Software
( http: // www.r-project.org / ). This study was approved by the Univer-
sity of California, Berkeley, University of California, San Francisco, and
Lawrence Berkeley National Laboratory institutional review boards
for human research. 
3. Results 
3.1. Patient characteristics 
Patient characteristics are shown in Table 1 . Patients with AD-
memory were signiﬁcantly older at PET and were more impaired
on CDR and CDR Sum-of-Boxes (CDR-SB) ( p = 0.03). No signiﬁcant
differences were found in gender, education, ApoE 4 status or MMSE. 
3.2. Neuropsychological evaluations 
Neuropsychological test batteries were available for most patients
(see Table 2 ). The mean interval between cognitive testing and PET
was 131 days (SD 207.6 days). As expected, AD-memory patients per-
formed poorly on verbal and visual memory tasks ( p = 0.03 on the Cal-
ifornia Verbal Learning Test 10-minute delayed recall, and p = 0.01 on
the modiﬁed Rey 10-minute delayed recall), whereas AD-visuospatial
patients showed lower performance on visuospatial tasks ( p = 0.02 for
modiﬁed Rey copy). The AD-language group performed signiﬁcantly
worse on sentence repetition ( p = 0.003), consistent with the deﬁcits
in auditory working memory previously reported in this group. 
3.3. Individual FDG and PiB components 
The number of estimated components using the AIC in our ob-
served data from 46 subjects was eight for the FDG-PET feature and
seven for the PiB-PET feature. Three of the eight FDG components
were associated with a particular clinical group with signiﬁcant pre-
dictor accuracy. A left inferior frontal and left temporoparietal hy-
pometabolism component was associated with AD-language with
an area under the curve (AUC) of 0.82 ( p = 0.011) ( Fig. 1 A). Two
components correlated with AD-visuospatial, one involving bilateral
occipito-parieto-temporal hypometabolism ( Fig. 1B ) and another in-
volving right posterior cingulate cortex (PCC) / precuneus and right
lateral parietal hypometabolism ( Fig. 1C ) with AUC measures of 0.85
( p = 0.009) and 0.69 ( p = 0.045), respectively. A fourth component
correlated at a trend level with AD-memory ( Fig. 1D ). This compo-
nent included predominantly bilateral inferior frontal, cuneus and
inferior temporal, and right inferior parietal hypometabolism (AUC
of 0.65, p = 0.062). The remaining FDG components showed no as-
sociation with clinical presentation (data not shown). These included
two components showing bilateral cerebellar hypometabolism, one
with bilateral medial orbito-frontal, inferior frontal, and right supe-
rior frontal hypometabolism, and one with cerebellar and superior
frontal hypometabolism. Supplementary Figs. S1–S4 illustrate the as-
sociations with clinical groups. 
None of the seven estimated PiB components (left PCC and lateral
parietal; right parieto-temporal; bilateral cerebellar; bilateral inferior
frontal; bilateral temporal, frontal, parietal, PCC / precuneus, and cere-
bellar; bilateral fronto-orbital and PCC / precuneus; bilateral fronto-
orbital and middle frontal) were signiﬁcant predictors in classifying
clinical groups after adjusting for age, sex, education, and ApoE 4. Mean FDG and PiB images of each of the three groups are provided
as Supplementary Figs. S5–S10 to allow for qualitative comparison of
PET patterns across groups. 
3.4. Joint FDG and PiB components 
We also explored the joint predictive value of FDG and PiB inde-
pendent components in correctly classifying a given diagnostic group
from the rest and among all possible pair combinations identiﬁed,
with paired glucose metabolism and amyloid deposition components
providing signiﬁcant improvement in classiﬁcation accuracy relative
to the ones based on unimodal components. The AD-memory re-
lated hypometabolism component (shown in Fig. 1D ) jointly with a
PiB component with amyloid deposition in the left posterior parietal
cortex and lateral parietal regions provided an AUC measure of 0.76
( Supplementary Fig. S11 ), signiﬁcantly larger than single modality
(AUC of 0.65, p < 0.01). The same PiB component when considered
jointly with the AD-language related hypometabolism component
( Fig. 1A ) signiﬁcantly ( p < 0.01) improved the classiﬁcation accuracy
from AUC = 0.82 to AUC = 0.87 ( Supplementary Fig. S12 ). A more
diffuse PiB component including temporal, parietal, PCC / precuneus,
and lateral and medial frontal amyloid deposition when considered
jointly with the ﬁrst AD-visuospatial related hypometabolism compo-
nent shown in Fig. 1B in a multimodal principal component analysis
diagnosis prediction model increased the unimodal hypometabolism
AUC measure of 0.85–0.88 ( p < 0.01) ( Supplementary Fig. S13 ). 
3.5. Correlated FDG and PiB components 
We found a signiﬁcant and spatially distributed component pair
across all subjects, depicting an association between FDG and PiB. In
this component pair, increased frontal and decreased PCC / precuneus
PiB binding was correlated with decreased FDG uptake in the frontal,
occipital and temporal regions ( Fig. 2 ). This component pair showed a
partial correlation of 0.75, with an FDR-corrected signiﬁcance level of
p < 10 −6 . The adjusted R 2 value of the ﬁtted model for this component
pair was 0.56 with p < 10 −8 . The FDG component in this pair was the
same component that showed, on its own, a trend correlation with
the AD-memory phenotype ( p = 0.062, Fig. 1D ). The PiB component
was not correlated with a speciﬁc phenotype (as was true for all PiB
components). This combined PiB-FDG component did not correlate
with a speciﬁc group. 
4. Discussion 
In this study we applied pICA to FDG-PET and PiB-PET data in
an attempt to better understand the relationships between glucose
metabolism, amyloid aggregation and clinical phenotype in AD. We
found that memory, language, and visuospatial-predominant clini-
cal variants of AD were associated with independent components of
glucose metabolism but not with speciﬁc patterns of β-amyloid depo-
sition. FDG and PiB jointly improved the classiﬁcation of one variant
from others, though the added effect of joint FDG-PiB versus FDG
alone was relatively small. Multivariate analyses further revealed an
inverse relationship between A β deposition and glucose metabolism
in the frontal cortex and PCC / precuneus, providing insight into the
biological interplay between these two biomarkers in key regions of
AD-related degeneration. 
4.1. Replicating previous univariate efforts using a multivariate 
approach 
Using pICA we replicated previous ﬁndings from univariate anal-
yses demonstrating that the clinical phenotype in AD is strongly
linked to anatomic patterns of glucose hypometabolism but not
to the spatial distribution of amyloid deposition ( Lehmann et al.,
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Table 2 
Neuropsychological proﬁles. 
Neuropsychological tests AD-memory ( n = 27) AD-language ( n = 10) AD-visuospatial ( n = 9) p values 
Memory 
CVLT-SF total learning ( / 36) 15.4 (6.9) 17.3 (6.8) 15.3 (3.8) 0.70 
CVLT-SF 10-min recall ( / 9) 1.1 (2.2) 3.5 (2.6) 2.1 (2.3) 0.03 * 
Modiﬁed Rey 10-min recall 
( / 17) 
2.2 (3.3) 6.0 (3.4) 2.9 (3.6) 0.01 * 
Language 
Boston naming test ( / 15) 10.4 (3.9) 9.8 (4.1) 10.6 (4.8) 0.91 
Syntax comprehension ( / 5) 3.3 (1.1) 3.0 (1.3) 2.1 (1.9) 0.10 
Letter ﬂuency (D words) 9.5 (5.0) 5.9 (3.3) 8.9 (4.0) 0.12 
Category ﬂuency (animals) 8.9 (4.4) 8.6 (4.1) 9.3 (4.6) 0.93 
Sentence repetition ( / 5) 3.3 (1.6) 1.5 (0.7) 3.2 (1.0) 0.003 * 
Repetition and working 
memory 
Digit span forward ( / 9) 5.1 (1.2) 4.2 (0.8) 5.3 (1.0) 0.18 
Digit span backward ( / 8) 3.7 (1.7) 3.0 (0.7) 2.4 (0.5) 0.05 
Executive functions 
Modiﬁed trails B correct 
lines / min 
10.2 (11.1) 9.1 (7.2) 5.7 (5.3) 0.56 
Stroop interference no. correct 17.3 (14.5) 16.9 (10.5) 14.6 (12.0) 0.90 
Visuospatial 
Modiﬁed Rey copy ( / 17) 11.8 (4.7) 14.0 (3.8) 7.6 (4.9) 0.02 * 
VOSP number location ( / 10) 6.9 (3.2) 8.0 (2.9) 4.2 (2.3) 0.06 
CATS 
Affect naming ( / 16) 11.7 (2.1) 12.3 (2.6) 12.0 (1.0) 0.82 
Face matching ( / 12) 10.7 (0.5) 11.7 (0.5) 9.7 (2.0) 0.13 
Calculation 
Arithmetics, written ( / 5) 3.3 (1.5) 3.0 (0.7) 2.8 (1.2) 0.51 
Abbreviations: California Verbal Learning Test (CVLT); Comprehensive Affect Testing System (CATS); Visual Object and Space Perception (VOSP). Missing data: modiﬁed Rey copy: 
1 AD-visuospatial; Boston naming: 2 AD-memory; syntax comprehension: 2 AD-memory, 1 AD-visuospatial; letter ﬂuency: 1 AD-memory; digit span forward: 20 AD-memory, 
4 AD-language, 5 AD-visuospatial; digit span backward: 1 AD-memory; modiﬁed trails: 7 AD-memory, 1 AD-language, 2 AD-visuospatial; Stroop: 6 AD-memory, 2 AD-language, 
2 AD-visuospatial; VOSP number location: 3 AD-memory, 1 AD-language, 3 AD-visuospatial; arithmetic: 1 AD-visuospatial; face matching: 10 AD-memory, 3 AD-language, 3 
AD-visuospatial; affect naming: 10 AD-memory, 3 AD-language, 4 AD-visuospatial. 
∗p < 0.05. 
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 013a ). Speciﬁcally, three independent glucose metabolism compo- 
ents were associated with speciﬁc clinical variants with high pre- 
ictor accuracy. First, a left inferior frontal and temporoparietal hy- 
ometabolism component was associated with AD-language. This is 
ongruent with previous studies demonstrating asymmetric left tem- 
oroparietal atrophy and hypometabolism in AD-language ( Gorno- 
empini et al., 2004 ; Rabinovici et al., 2008 ). Two AD-visuospatial 
elated components were found, one involving bilateral occipito- 
arieto-temporal hypometabolism and right PCC / lateral parietal hy- 
ometabolism. Again, this is in agreement with previous literature 
howing focal patterns of neurodegeneration with bilateral occipito- 
arieto-temporal atrophy and hypometabolism in AD-visuospatial 
 Lehmann et al., 2011 ; Migliaccio et al., 2009 ; Rosenbloom et al., 2011 ; 
hitwell et al., 2007 ). The AD-memory variant was not signiﬁcantly 
ssociated with a speciﬁc FDG component. This may be due to inclu- 
ion of relatively young AD patients in this group —patients with early 
ge-of-onset AD show relatively diffuse cognitive deﬁcits, including 
nvolvement of language and visuospatial domains that overlaps with 
he more focal AD-language and AD-visuospatial groups ( Lehmann et 
l., 2012 ; Migliaccio et al., 2009 ). However, at a trend level we found 
n association with a primarily frontal component, consistent with 
revious studies demonstrating that frontal involvement may distin- 
uish this variant of AD from others ( Lehmann et al. , 2013a and b ; 
igliaccio, 2009 ). 
In contrast with the syndrome-speciﬁc FDG components, PiB bind- 
ng was similar across clinical syndromes. The fact that none of the 
even estimated amyloid deposition components were signiﬁcant 
redictors of clinical conditions is congruent with most studies, which 
ave reported overlapping patterns of amyloid accumulation in dis- 
inct variants of AD ( Lehmann et al., 2013a ). Although single case 
eports and small series initially reported atypical binding patterns in 
D-language and AD-visuospatial ( Ng et al., 2007 ), larger series have found a diffuse pattern indistinguishable from typical AD and dissoci- 
ated from their focal structural and metabolic signatures ( de Souza et 
al., 2011 ; Lehmann et al., 2013a ; Leyton et al., 2011 ; Rabinovici et al., 
2008 ; Rosenbloom et al., 2011 ). Other studies comparing PiB binding 
in early and late age-of-onset AD found that differences in cogni- 
tive proﬁles could not be explained by the distribution or burden of 
PiB, which was identical in the groups ( Rabinovici et al., 2010 ). Al- 
together, our multivariate pICA strategy replicated previous ﬁndings 
using mass-univariate voxel-wise group comparisons. 
4.2. Linking metabolic patterns to speciﬁc networks of degeneration in 
the brain 
There is accumulating evidence that neurodegeneration occurs in 
speciﬁc networks in the brain ( Seeley et al., 2009 ; Zhou et al., 2012 ). 
A recent PET study ( Lehmann et al., 2013a ) showed that patterns of 
glucose hypometabolism in early-onset AD (EOAD), AD-language, and 
AD-visuospatial matched the network templates of executive-control, 
language, and visual networks, respectively. Notably, the FDG com- 
ponent linked by pICA in our study to AD-language bears a striking 
resemblance to the language network as identiﬁed by task-based or 
task-free fMRI ( Fig. 1A ; Shirer et al., 2012 ; Smith et al., 2009 ). The FDG
components linked with AD-visuospatial closely resemble a high- 
order visual network ( Fig. 1B ) and a right hemisphere posterior de- 
fault mode network (DMN; Fig. 1C ). These ﬁndings support a recently 
proposed model postulating that the emergence of heterogeneous AD 
phenotypes is related to the involvement of speciﬁc functional net- 
works that converge in the DMN ( Lehmann et al., 2013b ). This model 
integrates the hypothesis that aggregation of amyloid-beta may be 
driven by total ﬂow of neuronal activity (yielding diffuse and sym- 
metric patterns of PiB binding throughout ‘cortical hubs ’ ), whereas 
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Fig. 1. A) AD-language associated component included left inferior frontal and temporoparietal hypometabolism, B) AD-visuospatial related component 1 involved bilateral 
occipito-parieto-temporal hypometabolism, C) AD-visuospatial related component 2 involved right PCC / precuneus and right lateral parietal hypometabolism, and D) AD-memory 
associated component included predominantly bilateral inferior frontal, but also cuneus and inferior temporal, and right inferior parietal hypometabolism. Images are presented 
on a study-speciﬁc template in radiological convention. Supplementary Figures S1–S4 illustrate the associations with clinical groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 the aggregation of tau may be driven by transneuronal spread, gener-
ating patterns of neurodegeneration that coincide with speciﬁc func-
tional networks and ultimately lead to speciﬁc clinical phenotypes
( de Calignon et al., 2012 ; Seeley et al., 2009 ; Zhou et al., 2012 ). 
4.3. Spatially distributed relationship between amyloid deposition and 
metabolism 
An additional goal of this study was to explore spatially dis-
parate relationships between patterns of A β deposition and glucose
metabolism across a heterogenous AD population. We found a sig-
niﬁcant pICA component pair, in which increased frontal and de-
creased PCC / precuneus β-amyloid deposition was correlated with
decreased glucose metabolism in frontal, occipital and lateral tem-
poral regions. The patterns of PiB and FDG showed partial overlap
in medial prefrontal cortex, but were otherwise spatially disparate.
In the context of current models of the AD pathophysiologic cascade
( Jack et al., 2013 ), these ﬁndings suggest that A βmay exert both local
and remote effects on brain metabolism, the latter potentially due
to deafferentation of remote areas ( Bourgeat et al., 2010 ). Traditional
univariate approaches have similarly demonstrated both local and
remote correlations between PiB and FDG ( Cohen et al., 2009 ; Edison
et al., 2007 ; Engler et al., 2006 ). Our results are further congruent
with a recent report in mild cognitive impairment, which showed via
pICA that increased amyloid- β burden in the left precuneus / cuneus
and medial-temporal regions was associated with increased brainatrophy rates in the left medial-temporal and parietal regions, while
increased amyloid- βburden in bilateral precuneus / cuneus and pari-
etal regions was associated with increased brain atrophy rates in the
right medial temporal regions ( Tosun et al., 2011 ). 
Intriguingly, the PiB component in this pair consisted of increased
medial frontal and decreased PCC / precuneus binding. It is important
not to misinterpret this ﬁnding as evidence of low amyloid in PCC /
precuneus — rather it must be interpreted as a dynamic relationship
between regional levels of amyloid accumulation (high in the medial
frontal cortex, low in the PCC / precuneus) and brain metabolism. This
raises the possibility that variations in amyloid aggregation within key
regions of the DMN may modulate the pattern of neurodegeneration
in AD. Notably, hypometabolism in the prefrontal and occipital cortex
typically occurs in advanced clinical stages of AD ( Kim et al., 2005 ),
whereas medial prefrontal amyloid aggregation may be an early event
in the AD cascade ( Sepulcre et al., 2013 ), further underscoring the
relative resilience of the prefrontal cortex to AD pathology ( Furst et
al., 2012 ). While the reliability and signiﬁcance of this observation
will require further (and ideally longitudinal) study, our observation
underscores the complexity of the relationship between amyloid and
metabolism, which appears to vary by brain region and disease state
( Cohen et al., 2009 ; La Joie et al., 2012 ). Future studies with larger
sample sizes should also attempt to explore whether joint spatial
relationships between PiB and FDG correlate with speciﬁc clinical
features or neuropsychological proﬁles. 
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Fig. 2. Component pair depicting an association between hypometabolism and amyloid deposition. The spatial extent of this component pair showed that increased frontal 
and decreased PCC / precuneus β-amyloid deposition correlated with decreased glucose metabolism in the frontal, occipital and temporal regions. Images are presented on a 
study-speciﬁc template in radiological convention. Abbreviations. Amyloid beta (A β); Alzheimer’s disease (AD); default mode network (DMN); posterior cingulate cortex (PCC). 
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p.4. Role of multivariate analyses 
Use of multivariate techniques in the analysis of imaging data 
s gaining traction on the ﬁeld. Multivariate approaches evaluate 
orrelation / covariance of data across brain regions rather than pro- 
eeding on a voxel-by-voxel basis. They may be particularly helpful 
hen integrating multiple imaging modalities that capture different 
lements of disease pathophysiology ( Tosun et al., 2011 ). Unlike uni- 
ariate approaches, which treat each voxel or region as a spatially 
ndependent unit, multivariate analyses can explicitly examine the 
nter-relationship among these units and allow for better inference 
f the biological interconnectivity among brain regions ( Devanand 
t al., 2006 ; Eidelberg et al., 1991 ; Moeller and Eidelberg, 1997 ; see 
’Toole et al., 2007 for a review). Thus, results can be more easily 
nterpreted as a signature of neural networks, which may be a key 
lement to understanding the heterogeneity and pathophysiology of 
eurodegenerative disease ( Lehmann et al. , 2013a and b ; Seeley et 
l., 2009 ; Sepulcre et al., 2013 ; Zhang et al., 2012 ). Such approaches 
lso provide greater statistical power when compared with univari- 
te techniques, which are forced to employ very stringent, and often 
verly conservative, corrections for voxel-wise multiple comparisons. 
hese strengths can be leveraged to improve diagnostic classiﬁcation, 
s seen in our joint classiﬁcation analysis, where the combination of 
iB and FDG improved the discrimination of clinical variants com- 
ared to FDG alone ( Habeck et al., 2008 ). 4.5. Limitations 
This study has several limitations. While our patients met the NIA–
AA criteria for high-likelihood AD, pathological conﬁrmation of the 
diagnosis was not available. Our sample size was too small to explore 
relationships between individual components and speciﬁc cognitive 
tests. We could not include a structural imaging component because 
MRIs were performed on four different scanners with three differ- 
ent magnetic ﬁeld strengths. We did not correct PET data for partial 
volume loss, because (1) we were interested in FDG as a marker of 
neurodegeneration (rather than glucose metabolism per se), espe- 
cially in lieu of MRI data, such that it was advantageous to include the 
effects of atrophy and (2) atrophy correction of PiB data can introduce 
signiﬁcant bias, and the utility and optimal methods are controver- 
sial ( Thomas et al., 2011 ). In the past we have found identical results 
with and without atrophy correction examining similar relationships 
with univariate methods ( Lehmann et al., 2013a ; Rabinovici et al., 
2010 ; Rosenbloom et al., 2011 ). pICA assumes that measurements in 
each image voxel are independent and that the overall noise is iden- 
tically distributed assumptions which may not be fully met by PET 
data. PiB is a relatively novel tracer and may have ceiling effects or 
undescribed binding interactions that may limit data interpretation. 
Furthermore, PiB binds to ﬁbrillar forms of A β but not to the more 
toxic soluble A β aggregates. Finally, as discussed above, our cross- 
sectional design limits inferences about cause / effect and temporal 
relationships between amyloid aggregation and brain metabolism —
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 further, longitudinal studies will be needed to further clarify these
issues. 
5. Conclusions 
Multivariate analysis of PET data from a clinically heterogeneous
population of patients with probable AD showed that clinical pheno-
type correlated with independent components of glucose metabolism
but not with patterns of β-amyloid deposition. These ﬁndings are
strikingly similar to those derived from univariate paradigms and
provide additional support for involvement of speciﬁc functional net-
works in clinical variants of AD via A β-independent mechanisms.
pICA revealed that β-amyloid deposition and glucose metabolism
show both local and spatially disparate relationships across the brain,
highlighting the complexity of the relationship between molecular
pathology and neurodegeneration in AD. Further clarifying the re-
lations between these processes is of utmost importance given the
effort to develop treatments targeting speciﬁc events in the AD patho-
physiological cascade. 
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